News

A leading podiatrist and business owner who has completed nearly 1000 treatments using our revolutionary Swift® device has hailed its potential as the future of treating painful skin lesions.

Our co-founder Gary Beale, has won a major life sciences award recognising outstanding business leadership. With a career spanning more than 25 years, he has led the company through a series of impressive milestones.

A new research study has shown that four out of every five patients suffering from a common skin condition are likely to see successful outcomes after using our microwave technology.

Emblation has moved into its stunning new £4m office in Stirling, ushering in the start of a new era. We have invested heavily in our new HQ Emblation House – which boasts a sauna, gym, chillout area and a 90-person auditorium.

We at Emblation have partnered with one of the top aesthetic equipment distributors in Singapore to expand the global reach of our innovative microwave device.

The Emblation team is undertaking a rigorous clinical trial which could transform the fortunes of our microwave treatments in the US.

Technology pioneered by our Emblation team has featured in promising new research which could deliver less painful and more effective treatment for cervical cancer patients.